Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Ackman Finally Loosens Grip On Allergan; Withdraws Request For Special Shareholder Meeting
Bidness Etc.
Thursday, November 20, 2014 - 9:56am
tags:
Bill Ackman, Allergan, Valeant Pharmaceuticals, M&A
Boston Scientific: Our new Synergy stent is as good as Promus
Mass Device
Thursday, November 20, 2014 - 9:39am
tags:
Boston Scientific, Synergy stent, PROMUS, devices
Britain begins review to speed access to new drugs
Yahoo/Reuters
Thursday, November 20, 2014 - 9:23am
tags:
UK, drug approvals
Lilly Shares Climb Despite Sales, Revenue Declines
Seeking Alpha
Thursday, November 20, 2014 - 9:11am
tags:
Eli Lilly
NIH and FDA Toughen Rules for Reporting Clinical Trial Results
WSJ Pharmalot
Thursday, November 20, 2014 - 9:06am
tags:
NIH, FDA, clinical trial data
Merrimack pancreatic cancer product candidate fast tracked
Seeking Alpha
Thursday, November 20, 2014 - 9:04am
tags:
pancreatic cancer, Merrimack Pharmaceuticals, FDA, fast track
Endo Announces Launch of Generic Version of Valcyte
Yahoo
Thursday, November 20, 2014 - 8:25am
tags:
Endo Health Solutions, Valcyte, earnings
Ranbaxy Loses Bid to Block Rivals in Generic Drugs Fight
Bloomberg
Thursday, November 20, 2014 - 8:24am
tags:
Ranbaxy, generics
Mallinckrodt tops, no outlook
Yahoo/Investors Business Daily
Thursday, November 20, 2014 - 8:22am
tags:
Mallinckrodt, earnings
World’s Drug Bill Will Reach $1.3 Billion in 2018: Study
Bloomberg
Thursday, November 20, 2014 - 8:21am
tags:
drug pricing, hepatitis C
Celgene Up on Encouraging Long-Term Phase III Otezla Data
Yahoo/Zacks.com
Wednesday, November 19, 2014 - 5:37pm
tags:
Celgene, Otezla
Is Pfizer Spending Enough On R&D?
Seeking Alpha
Wednesday, November 19, 2014 - 5:32pm
tags:
Pfizer, R&D
Gilead Sciences: The Worst Case Scenario?
Barron's
Wednesday, November 19, 2014 - 5:31pm
tags:
Gilead Sciences, hepatitis C, Harvoni, Sovaldi
Sanofi makes case for experimental drugs in pipeline
CNBC
Wednesday, November 19, 2014 - 5:30pm
tags:
Sanofi
Shire relocates 500 jobs to Massachusetts
Reuters
Wednesday, November 19, 2014 - 10:16am
tags:
Shire, Massachusetts, R&D
That’s Funny, you Look Just Like Allergan CEO David Pyott
WSJ Pharmalot
Wednesday, November 19, 2014 - 10:14am
tags:
Allergan, Actavis, M&A, David Pyott
Sanofi Said to Consider Smith & Nephew, Takeda for CEO
Bloomberg
Wednesday, November 19, 2014 - 10:11am
tags:
Sanofi, Pharma CEOs, Takeda, Smith & Nephew
Clovis Lung Cancer Update Swings Momentum to Rival, Slightly
TheStreet.com
Wednesday, November 19, 2014 - 10:05am
tags:
Clovis Oncology, AstraZeneca, rociletinib, lung cancer
IPO Preview: Second Sight Medical Products
Seeking Alpha
Wednesday, November 19, 2014 - 10:04am
tags:
IPOs, Second Sight, devices
Pharma deploys reps with helping hands to target stealth prescribers
Fierce Pharma Marketing
Wednesday, November 19, 2014 - 9:05am
tags:
drug reps, physicians

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.